Dopamine‐Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|28|10|1337-1342

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.28, Iss.10, 2013-09, pp. : 1337-1342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Balancing the basal ganglia circuitry: A possible new role for dopamine D2 receptors in health and disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 895-903

John Wiley & Sons Inc

Access to resources Recommend Favorite

Electrical Inhibition of Basal Ganglia Nuclei in Parkinson’s Disease: Long-Term Results

By  

Stereotactic and Functional Neurosurgery, Vol. 72, Iss. 2-4, 2000-04 ,pp. : 202-207

Karger

Access to resources Recommend Favorite

Neurophysiological fingerprints of X‐linked dystonia‐parkinsonism: A model basal ganglia disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 6, 2015-05 ,pp. : 873-875

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. : 1859-1860

John Wiley & Sons Inc

Access to resources Recommend Favorite

Germinoma of the Basal Ganglia

By  

Pediatric Neurosurgery, Vol. 40, Iss. 6, 2005-03 ,pp. : 306-311

Karger

Access to resources Recommend Favorite